Aspira Women's Health investor relations material

Aspira Women's Health Inc., together with its subsidiaries, is a clinical stage company. The Company focuses on developing and commercializing diagnostic tests for gynecologic disease in the United States. Aspira develops molecular diagnostic tests using multiplex technology that addresses the limitations of traditional single-biomarker methods by simultaneously analyzing multiple biomarkers in a single sample.